Education
About Us
Working with TipRanks
Follow Us
Mega Genomics Limited (HK:6667)
:6667
Total Valuation
Mega Genomics Limited has a market cap or net worth of HK$1.61B. The enterprise value is HK$1.98B.
Market CapHK$1.61B
Enterprise ValueHK$1.98B
Share Statistics
Mega Genomics Limited has 224,300,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding224,300,200
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Mega Genomics Limited’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 2.21%.
Return on Equity (ROE)0.05
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)2.21%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee707.01K
Profits Per Employee140.36K
Employee Count214
Asset Turnover0.19
Inventory Turnover14.29
Valuation Ratios
The current PE Ratio of Mega Genomics Limited is 65.80. Mega Genomics Limited’s PEG ratio is 1.18.
PE Ratio65.80
PS Ratio0.00
PB Ratio3.83
Price to Fair Value3.06
Price to FCF-195.72
Price to Operating Cash Flow-342.65
PEG Ratio1.18
Income Statement
In the last 12 months, Mega Genomics Limited had revenue of 151.30M and earned 30.04M in profits. Earnings per share was 0.14.
Revenue151.30M
Gross Profit88.30M
Operating Income18.53M
Pretax Income36.18M
Net Income30.04M
EBITDA52.42M
Earnings Per Share (EPS)0.14
Cash Flow
In the last 12 months, operating cash flow was 111.33M and capital expenditures -23.80M, giving a free cash flow of 87.53M billion.
Operating Cash Flow111.33M
Free Cash Flow87.53M
Free Cash Flow per Share0.39
Dividends & Yields
Mega Genomics Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.53
52-Week Price Change-25.77%
50-Day Moving Average7.20
200-Day Moving Average7.82
Relative Strength Index (RSI)46.97
Average Volume (3m)0.00
Important Dates
Mega Genomics Limited upcoming earnings date is Aug 28, 2025, TBA (Confirmed).
Last Earnings DateMar 31, 2025
Next Earnings DateAug 28, 2025
Ex-Dividend Date―
Financial Position
Mega Genomics Limited as a current ratio of 5.84, with Debt / Equity ratio of 1.78%
Current Ratio5.84
Quick Ratio5.80
Debt to Market Cap0.01
Net Debt to EBITDA-8.96
Interest Coverage Ratio16.51
Taxes
In the past 12 months, Mega Genomics Limited has paid 6.14M in taxes.
Income Tax6.14M
Effective Tax Rate0.17
Enterprise Valuation
Mega Genomics Limited EV to EBITDA ratio is 28.74, with an EV/FCF ratio of 11.81.
EV to Sales9.96
EV to EBITDA28.74
EV to Free Cash Flow11.81
EV to Operating Cash Flow9.20
Balance Sheet
Mega Genomics Limited has HK$508.93M in cash and marketable securities with ¥41.42M in debt, giving a net cash position of -HK$467.51M billion.
Cash & Marketable SecuritiesHK$508.93M
Total Debt¥41.42M
Net Cash-HK$467.51M
Net Cash Per Share-HK$2.08
Tangible Book Value Per ShareHK$3.04
Margins
Gross margin is 56.08%, with operating margin of 12.24%, and net profit margin of 19.85%.
Gross Margin56.08%
Operating Margin12.24%
Pretax Margin23.91%
Net Profit Margin19.85%
EBITDA Margin34.65%
EBIT Margin24.65%
Analyst Forecast
The average price target for Mega Genomics Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―